Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
13,913,023
-
Share change
-
-576,630
-
Total reported value
-
$835,272,340
-
Put/Call ratio
-
0%
-
Price per share
-
$60.00
-
Number of holders
-
107
-
Value change
-
-$16,214,267
-
Number of buys
-
52
-
Number of sells
-
40
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2020
As of 31 Dec 2020,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,913,023 shares.
The largest 10 holders included
Redmile Group, LLC, BlackRock Inc., FMR LLC, FRAZIER MANAGEMENT LLC, CREDIT SUISSE AG/, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, FARALLON CAPITAL MANAGEMENT LLC, and Point72 Asset Management, L.P..
This page lists
107
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.